Immunogenicity 12124
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
OR5D16
Transcript ID
uc010rio.2
HLA INFO
C*12:03
TCR INFO
No TCR info found!
Full length protein sequence (328 aa)
MFLTE
1
RNTTS
6
EATFT
11
LLGFS
16
DYLEL
21
QIPLF
26
FVFLA
31
VYGFS
36
VVGNL
41
GMIVI
46
IKINP
51
KLHTP
56
MYFFL
61
NHLSF
66
VDFCY
71
SSIIA
76
PMMLV
81
NLVVE
86
DRTIS
91
FSGCL
96
VQFFF
101
FCTFV
106
VTELI
111
LFAVM
116
AYDHF
121
VAICN
126
PLLYT
131
VAISQ
136
KLCAM
141
LVVVL
146
YAWGV
151
ACSLT
156
LACSA
161
LKLSF
166
HGFNT
171
INHFF
176
CELSS
181
LISLS
186
YPDSY
191
LSQLL
196
LFTVA
201
TFNEI
206
STLLI
211
ILTSY
216
AFIIV
221
TTLKM
226
PSASG
231
HRKVF
236
STCAS
241
HLTAI
246
TIFHG
251
TILFL
256
YCVPN
261
SKNSR
266
HTVKV
271
ASVFY
276
TVVIP
281
LLNPL
286
IYSLR
291
NKDVK
296
DAIRK
301
IINTK
306
YFHIK
311
HRHWY
316
PFNFV
321
IEQ
326
Mutation Information
DNA mutation:
None
Peptide Range:
115 ~ 139
Mut AA position:
127 (13 in Wild Type peptide)
Alignment
Wild Type:
"ILFAVMAYDHFVAICNPLLYTVAIS
||||||||||||.||||||||||||
Mutant:
ILFAVMAYDHFVVICNPLLYTVAIS"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) OR5D16
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay